|
Yu.G. Alyaev, A.M. Pshikhachev, A.N. Perekalina
The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination
|
№5 / 2016
|
|
P.V. Glybochko, Yu.G. Alyaev, A.M. Pshikhachev, N.I. Sorokin, A.M. Dymov
Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia
|
№5 / 2016
|
|
P.V. Glybochko, J.G. Alyaev, N.V. Potoldykova, K.A. Polyakovsky, A.Z. Vinarov, A.I. Glukhov, S.A. Gordeev
The role of telomerase activity in non-invasive diagnostics of bladder cancer
|
№4 / 2016
|
|
I.V. Kosova
The role of viruses in the etiology of bladder cancer
|
№3 / 2016
|
|
I.V. Kosova
Oncogenetic factors of some herpesvirus infection agents
|
№3 / 2016
|
|
D.S. Mikhailenko, M.V. Nemtsova
Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets
|
№1 / 2016
|
|
S.P. Darenkov, S.V. Kotov, A.A. Proskokov, A.G. Jusufov, S.V. Belomytcev, E.V. Badovskaya, R.R. Gubaidullin, I.S. Pinchuk
Importance of «surgery of quick recovery» program for surgical treatment of bladder tumors
|
№6 / 2015
|
|
V.N. Pavlov, A.M. Pushkarev, Ya.V. Kondratenko, R.I. Safiullin, A.V. Alekseev
Markers of kidney damage and nephroprotective therapy in radical cystectomy
|
№5 / 2015
|
|
V.I. Vtorenko, R.N. Trushkin, A.E. Lubennikov, O.L. Podkorytova, P. I. Motin
Bilateral nephroureterectomy with cystoprostatectomy ad bloc and lymphadenectomy in a patient with end-stage renal failure and cancer of the urinary bladder T2BN0M0
|
№2 / 2015
|
|
A.N. Shevchenko, A.I. Shihljarova, E.V. Filatova, O.V. Tarnopol’skaja, T.A. Kurkina, S.G. Seleznev, I.A. Homu-tenko, D.A. Shvyrev
Modified intravesical chemotherapy of bladder cancer
|
№1 / 2015
|
Русский
